Advanced Medical Solutions Group (LON:AMS) Issues Quarterly Earnings Results

Advanced Medical Solutions Group (LON:AMS) released its quarterly earnings data on Thursday. The company reported GBX 10.65 ($0.14) EPS for the quarter, Digital Look Earnings reports. Advanced Medical Solutions Group had a net margin of 8.49% and a return on equity of 4.57%.

Advanced Medical Solutions Group Stock Down 1.7 %

Shares of LON:AMS opened at GBX 201 ($2.61) on Friday. Advanced Medical Solutions Group has a 52-week low of GBX 176.60 ($2.29) and a 52-week high of GBX 275.83 ($3.58). The firm has a market capitalization of £434.01 million, a P/E ratio of 38.95, a P/E/G ratio of 5.00 and a beta of 0.74. The stock has a 50 day moving average price of GBX 211.58 and a 200-day moving average price of GBX 212.49. The company has a debt-to-equity ratio of 37.01, a quick ratio of 4.58 and a current ratio of 8.39.

Advanced Medical Solutions Group Increases Dividend

The firm also recently disclosed a dividend, which will be paid on Friday, June 20th. Shareholders of record on Thursday, May 29th will be issued a GBX 1.83 ($0.02) dividend. The ex-dividend date is Thursday, May 29th. This represents a yield of 0.89%. This is a boost from Advanced Medical Solutions Group’s previous dividend of $0.77. Advanced Medical Solutions Group’s dividend payout ratio (DPR) is 38.76%.

Analyst Ratings Changes

Separately, Berenberg Bank reiterated a “buy” rating and issued a GBX 300 ($3.89) price objective on shares of Advanced Medical Solutions Group in a report on Wednesday.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.